# Cabaletta Bio, Inc.: Form 8-K/A, filed Mar 14, 2022

- Company: [Cabaletta Bio, Inc.](/companies/caba.md) (CIK 1759138)
- Form: 8-K/A
- Filed: 2022-03-14
- Accepted by EDGAR: Mar 14, 2022, 08:00 ET
- Period: 2022-03-03
- Accession: 0001193125-22-074084
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1759138/000119312522074084/d312447d8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1759138/000119312522074084/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1759138/000119312522074084/d312447d8ka.htm

Filed Mar 14, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-074084. Last ingested by Listed: Nov 12, 2026, 17:57 ET. No prices; not investment advice.